4.3 Article

State-dependent inhibition of BK channels by the opioid agonist loperamide

期刊

JOURNAL OF GENERAL PHYSIOLOGY
卷 153, 期 9, 页码 -

出版社

ROCKEFELLER UNIV PRESS
DOI: 10.1085/jgp.202012834

关键词

-

资金

  1. National Institutes of Health [R01 GM126581, R01 NS078152]

向作者/读者索取更多资源

The drug loperamide has been found to inhibit the activity of large-conductance Ca2+-activated K+ (BK) channels, which may contribute to its therapeutic effects.
Large-conductance Ca2+-activated K+ (BK) channels control a range of physiological functions, and their dysfunction is linked to human disease. We have found that the widely used drug loperamide (LOP) can inhibit activity of BK channels composed of either alpha-subunits (BK alpha channels) or alpha-subunits plus the auxiliary gamma 1-subunit (BK alpha/gamma 1 channels), and here we analyze the molecular mechanism of LOP action. LOP applied at the cytosolic side of the membrane rapidly and reversibly inhibited BK current, an effect that appeared as a decay in voltage-activated BK currents. The apparent affinity for LOP decreased with hyperpolarization in a manner consistent with LOP behaving as an inhibitor of open, activated channels. Increasing LOP concentration reduced the half-maximal activation voltage, consistent with relative stabilization of the LOP-inhibited open state. Single-channel recordings revealed that LOP did not reduce unitary BK channel current, but instead decreased BK channel open probability and mean open times. LOP elicited use-dependent inhibition, in which trains of brief depolarizing steps lead to accumulated reduction of BK current, whereas single brief depolarizing steps do not. The principal effects of LOP on BK channel gating are described by a mechanism in which LOP acts as a state-dependent pore blocker. Our results suggest that therapeutic doses of LOP may act in part by inhibiting K+ efflux through intestinal BK channels.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据